Form 4: LifeStance Health Group Chief Medical Officer Acquires 62,413 Restricted Stock Units
SEC Form 4 Filing
Ujjwal Ramtekkar, Chief Medical Officer of LifeStance Health Group, acquired 62,413 restricted stock units on March 8, 2024.
Summary
- On March 8, 2024, Ujjwal Ramtekkar, the Chief Medical Officer of LifeStance Health Group, acquired 62,413 restricted stock units (RSUs).
- Each RSU represents a contingent right to receive one share of LifeStance Health Group's common stock.
- Following this transaction, Ramtekkar directly owns 62,413 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a common practice for publicly traded companies. It provides transparency into the holdings and transactions of company executives.
Stakeholder Impact
- The acquisition of RSUs by the Chief Medical Officer could be viewed positively by shareholders as it aligns the executive's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of transaction: Ujjwal Ramtekkar acquired 62,413 restricted stock units. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.